INFY:NYSEInfosys Limited Analysis
Data as of 2026-04-10 - not real-time
Latest Price
Risk Level: Medium
Executive Summary
Infosys (INFY) trades at $13.44, well below its 50‑day SMA of $14.47 and 200‑day SMA of $16.67, signaling a bearish technical backdrop. The RSI sits at 44, indicating neutral momentum, while the MACD histogram is positive, suggesting a tentative bullish signal amid declining volume. Fundamentals remain solid: a P/E of 17.5 versus an industry average of 33.9, a strong ROE of 32.7%, and a dividend yield of 3.75% with a 67% payout ratio. However, the DCF fair value of $12.56 is lower than the current price, implying limited upside from a pure discounted cash flow perspective, though analyst consensus targets around $16.6 point to a potential 23% upside. Recent strategic AI collaborations (Incora, Harness) and the pending acquisition of Optimum Healthcare IT add growth catalysts, while the company’s low beta (0.74) and robust cash position mitigate market volatility risks.
Market Outlook
Short Term
< 1 yearKey Factors
- Price below short‑ and medium‑term moving averages
- Decreasing volume and bearish trend direction
- Support level near $12.57 providing downside cushion
Medium Term
1–3 yearsKey Factors
- Analyst price targets imply ~23% upside
- Attractive valuation relative to industry peers (low P/E)
- Strategic AI partnerships expanding serviceable addressable market
Long Term
> 3 yearsKey Factors
- Strong ROE and cash generation supporting dividend sustainability
- Growth potential from AI and digital transformation initiatives
- Solid balance sheet with net cash position and manageable debt
Key Metrics & Analysis
Financial Health
Technical Analysis
Valuation
Risk Assessment
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.